Therefore, observations of only a modest 50% drop in the level of GLI1 RNA in tumour cells treated with high doses of cyclopamine do not support the argument that the HH pathway is driving both GLI1 expression and the growth of such cells [66,67]. This evidence concerns the gene GLI1 and neoplasm.